-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fn5pJTY7bpWp5bXZ68jBlTu/e+Jj3IM9yIMIdBP+RwD/JSGnhMK7UgF9AemFcZTl ul+3PoE0BGu3fPoPEFj/CA== 0001193125-05-009828.txt : 20050121 0001193125-05-009828.hdr.sgml : 20050121 20050121164545 ACCESSION NUMBER: 0001193125-05-009828 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050117 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050121 DATE AS OF CHANGE: 20050121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYNACQ HEALTHCARE INC CENTRAL INDEX KEY: 0000890908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760375477 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21574 FILM NUMBER: 05542030 BUSINESS ADDRESS: STREET 1: 10304 INTERSTATE 10 EAST STREET 2: SUITE 369 CITY: HOUSTON STATE: TX ZIP: 77029 BUSINESS PHONE: 7136736639 MAIL ADDRESS: STREET 1: 10304 I-10 EAST STREET 2: SUITE 369 CITY: HOUSTON STATE: TX ZIP: 77029 FORMER COMPANY: FORMER CONFORMED NAME: DYNACQ INTERNATIONAL INC DATE OF NAME CHANGE: 19960126 8-K 1 d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 17, 2005

 


 

Dynacq Healthcare, Inc.

(Exact name of registrant as specified in its charter)

 


 

Delaware   000-21574   76-0375477

(State or other jurisdiction of

incorporation or organization)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

10304 Interstate 10 East, Suite 369

Houston, Texas 77029

(Address of principal executive offices and zip code)

 

(713) 378-2000

(Registrant’s telephone number, including area code)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

(c)(1) On January 17, 2005, the Registrant appointed Alan Beauchamp as an Executive Vice President and its Chief Operating Officer.

 

(2) Mr. Beauchamp, age 52, has been since May 2003 (and continues to be) a partner in Medical Links International, L.P., a private management and procurement entity that either directly or through its affiliates, services the medical healthcare industry. Mr. Beauchamp served as the Chief Executive Officer of Doctors Hospital Parkway and Doctors Hospital Tidwell for HEALTHPLUS+ Corporation from March 2004 until his appointment with the Registrant. Prior to joining the HEALTHPLUS+ Corporation, Mr. Beauchamp was the President and a principal, as well as an investor, for four software companies, including Optimum Inc., a healthcare information system software development company, from 1997 to 2003. Prior to his position as President of such software companies, Mr. Beauchamp was a principal and the President and Chief Executive Officer of Premier Analytical Laboratories, a SAMSHA approved forensic drug testing laboratory in the United States. He was also a principal of Mid-America Healthcare Group that owned four healthcare facilities in the Houston area from 1984 to 1996. Mr. Beauchamp has spent 29 years in the healthcare industry focused on hospital operations.

 

Mr. Beauchamp’s occupation and employment prior to his appointment as an Executive Vice President and the Chief Operating Officer with the Registrant did not involve a parent, subsidiary or other affiliate of the Registrant.

 

(3) There is no employment agreement with Mr. Beauchamp. In connection with his appointment, effective January 20, 2005, our Compensation Committee granted Mr. Beauchamp options to acquire 100,000 shares of our common stock at $5.00 per share, such options vesting in equal increments for the four years commencing on the anniversary date of the grant.

 

Item 8.01 Other Events.

 

On January 18, 2005, the Registrant issued a press release announcing the appointment of Mr. Alan Beauchamp to the officer position of Chief Operating Officer. The press release is attached hereto as an exhibit and is incorporated herein in its entirety.

 

Item 9.01 Financial Statements and Exhibits

 

  (c) Exhibits.

 

Exhibit

Number


  

Description


*Exhibit 99.1    Press release dated January 18, 2005.

* Filed herewith


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dynacq Healthcare, Inc.
By:  

/s/ Philip S. Chan


    Philip S. Chan,
    Chief Financial Officer

 

Date: January 21, 2005


Exhibit Index

 

Exhibit

Number


 

Description


*Exhibit 99.1   Press release dated January 18, 2005.

* Filed herewith
EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

DYNACQ HEALTHCARE, INC. ANNOUNCES

HIRING OF CHIEF OPERATING OFFICER

 

Dynacq Healthcare, Inc. (the “Company”) (OTCBB:DYII - News) announced the hiring of Alan Beauchamp as its new Chief Operating Officer.

 

Mr. Beauchamp brings exceptional healthcare industry, business management and leadership experience to Dynacq. During his career, he was the President/CEO for several healthcare-related businesses. Prior to joining the Company, Mr. Beauchamp was the CEO of Doctors Hospital Parkway and Doctors Hospital Tidwell. In this role, he successfully evaluated and initiated positive endeavors at those healthcare facilities for HEALTHPLUS+ Corporation.

 

“This appointment will solidify and strengthen Dynacq’s senior management team,” said Chiu Chan, Dynacq’s CEO. “I am delighted that Alan Beauchamp has agreed to step into the COO’s role at this time. Alan will provide the leadership, continuity of Dynacq’s vision and the business experience necessary to continue to move the Company forward and position it for long-term growth. Given his extensive experience in the healthcare industry, we realized that Alan is ideally suited to take on this important responsibility,” Chan continued.

 

Prior to joining the HEALTHPLUS+ Corporation, Mr. Beauchamp was the President/CEO, as well as an investor, for four software companies, including Optimum Inc., a healthcare information system software development company (sold in 2001). Prior to his position as President/CEO of those software companies, Mr. Beauchamp was a principal and President/CEO of Premier Analytical Laboratories, one of only 72 SAMSHA approved forensic drug testing laboratories in the United States. He was also a principal of Mid-America Healthcare Group that owned four healthcare facilities in the Houston area. Throughout his distinguished career, Mr. Beauchamp has spent 29 years in the healthcare industry focused on hospital operations.

 

Mr. Beauchamp has a Bachelor of Business Administration degree in Accounting from Texas A&M University.

 

Dynacq Healthcare Inc. (www.dynacq.com) is a holding company. Its subsidiaries provide surgical healthcare services and related ancillary services through hospital facilities and outpatient surgical centers.

 

Contact:

 

Dynacq Healthcare Inc., Houston

Christina L. Gutel-Williams, 713-378-2000

christina.gutel@dynacq.com

 

Certain statements included in this press release, which are not historical facts, are forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our expectations or beliefs and involve certain risks and uncertainties, including those described in our public filings with the United States Securities and Exchange Commission; also including, but not limited to, changes in interest rates, competitive pressures, changes in customer mix, changes in third party reimbursement rates, financial stability of major customers, changes in government regulations or the interpretation of these regulations, changes in supplier relationships, growth opportunities, cost savings, revenue enhancements, synergies and other benefits anticipated from acquisition transactions, difficulties relative to integrating acquired businesses, the accounting and tax treatment of acquisitions, and asserted and unasserted claims, which could cause actual results to differ from those in the forward-looking statements. The forward-looking statements by their nature involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date herein.

-----END PRIVACY-ENHANCED MESSAGE-----